MeropenemThird Party Manufacturing in India

Meropenem works by inhibiting bacterial cell wall synthesis.

It binds to penicillin-binding proteins (PBPs), which are essential for building the bacterial cell wall. This prevents the cross-linking of peptidoglycan chains, leading to cell lysis and rapid bacterial cell death.

Unlike many other beta-lactams, meropenem is highly resistant to degradation by beta-lactamases and is highly effective for serious bacterial infections caused by resistant pathogens.

Therapeutic Uses

Meropenem is prescribed for the treatment of:

• Complicated Intra-Abdominal Infections: Treats severe infections caused by a mix of aerobic and anaerobic bacteria.
• Bacterial Meningitis: Effective due to its excellent penetration into the cerebrospinal fluid (CSF).
• Hospital-Acquired Pneumonia (HAP): Frequently used for severe respiratory infections in critical care settings.
• Complicated Skin and Skin Structure Infections: Used for severe deep tissue infections.

Why Manufacturers Choose Meropenem

Meropenem is a critical broad-spectrum injectable antibiotic, heavily demanded in hospital and ICU setups across the globe. Due to its resistance to many beta-lactamases, it remains a gold-standard choice for treating complicated infections.

This makes Meropenem one of the most sought-after molecules for third party manufacturing in India, with consistent demand from critical care franchise divisions and export-oriented companies targeting the hospital supply chain.